Because prostate cancer is the most common cancer in men and the positive biopsy rate is approximately 30%, the prostate biopsy is one of the most common procedures a urologist will perform. Although, most urologists are facile at performing the prostate biopsy, new information has been obtained...
64 When should patients undergo prostate biopsy? Decision analysis using differences in the health-related quality-of-life between pre-biopsy healthy men and patients with castration-resistant prostate cancerdoi:10.1016/S1569-9056(16)60066-0J. Ishioka...
The value of different screening tests in predicting prostate biopsy outcome in screening for prostate cancer data from a multicenter study (ERSPC) BACKGROUND Although serum PSA testing is widely used as a screening test for prostate cancer (PC), it is known that it is not specific for PC. ...
prostate biopsyProstate cancer increases with each decade of life. Eight percent of men have invasive prostate cancer in their 20s; 80% of men have invasive prostate cancer in their 70s. Prostate cancer is easily cured and the actual death rate is very low. The common development of prostate ...
作者: R. Chowdhury and A. Abbas and S. Idriz and A. Hoy and E.E. Rutherford and J.M. Smart 摘要: Aim To determine whether patients undergoing transrectal ultrasound (TRUS)-guided prostate biopsy with increased sampling numbers are more likely to experience bleeding complications and whether ...
Your doctor says you need a biopsy If you have had one or more PSA blood tests with an elevated or rising PSA, your doctor may recommend an in-office biopsy guided by ultrasound. This is because only tissue samples can determine whether you have prostate cancer. Right? Actually, no. ...
A transperineal approach to prostate cancer biopsies without the need for preventive antibiotics could eliminate risk for infection, according to results of a randomized trial.No men who underwent transperineal biopsy developed an infection in the study,
"I think generally starting at age 50 is a very reasonable number to start getting a PSA. But if you are African American or have a significant family history of prostate cancer or have agenetic alterationthat might predispose to prostate cancer, then you should probably get one even earlier...
BARCODE1 is an empirical pilot study of implementing a PRS to risk stratify screening and has recently published initial findings3. Of 1434 men sent a written invitation, 297 provided usable samples for genotyping; 25 were found to be at high risk, 18 of whom underwent a prostate biopsy, wit...
cfDNA refers to circulating DNA fragments that originate from tumor cells, thus representing a form of liquid biopsy that carries the mutations and methylomic abnormalities present in the tumor [41]. The first FDA-approved assay, Epi proColon®, became available to the market in 2016 and is ...